Select Medical Holdings Stock Price To Sales
| S24 Stock | EUR 19.50 0.30 1.56% |
Select Medical Holdings fundamentals help investors to digest information that contributes to Select Medical's financial success or failures. It also enables traders to predict the movement of Select Stock. The fundamental analysis module provides a way to measure Select Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Select Medical stock.
Select |
Select Medical Holdings Company Price To Sales Analysis
Select Medical's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Select Medical Price To Sales | 0.46 X |
Most of Select Medical's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Select Medical Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Select Medical Holdings has a Price To Sales of 0.4587 times. This is 97.86% lower than that of the Healthcare sector and 81.35% lower than that of the Medical Care industry. The price to sales for all Germany stocks is 95.98% higher than that of the company.
Select Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Select Medical's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Select Medical could also be used in its relative valuation, which is a method of valuing Select Medical by comparing valuation metrics of similar companies.Select Medical is currently under evaluation in price to sales category among its peers.
Select Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0316 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 7.52 B | |||
| Shares Outstanding | 126.98 M | |||
| Shares Owned By Insiders | 18.39 % | |||
| Shares Owned By Institutions | 82.44 % | |||
| Price To Earning | 13.69 X | |||
| Price To Book | 2.72 X | |||
| Price To Sales | 0.46 X | |||
| Revenue | 6.33 B | |||
| Gross Profit | 1.1 B | |||
| EBITDA | 635.51 M | |||
| Net Income | 158.99 M | |||
| Cash And Equivalents | 147.82 M | |||
| Cash Per Share | 1.09 X | |||
| Total Debt | 3.84 B | |||
| Debt To Equity | 248.40 % | |||
| Current Ratio | 1.19 X | |||
| Book Value Per Share | 8.82 X | |||
| Cash Flow From Operations | 284.82 M | |||
| Earnings Per Share | 1.22 X | |||
| Target Price | 47.0 | |||
| Number Of Employees | 37.8 K | |||
| Beta | 1.38 | |||
| Market Capitalization | 3.33 B | |||
| Total Asset | 7.67 B | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 7.67 B | |||
| Last Dividend Paid | 0.5 |
About Select Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Select Medical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Select Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Select Medical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Select Stock
When determining whether Select Medical Holdings is a strong investment it is important to analyze Select Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Select Medical's future performance. For an informed investment choice regarding Select Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.